oncotherics limited Company Information
Company Number
06940617
Next Accounts
Mar 2026
Shareholders
biostatus ltd
stefan ogrodzinski
View AllGroup Structure
View All
Industry
Non-trading company
Registered Address
56a charnwood road, shepshed, leicestershire, LE12 9NP
Website
www.oncotherics.comoncotherics limited Estimated Valuation
Pomanda estimates the enterprise value of ONCOTHERICS LIMITED at £211.7k based on a Turnover of £490.2k and 0.43x industry multiple (adjusted for size and gross margin).
oncotherics limited Estimated Valuation
Pomanda estimates the enterprise value of ONCOTHERICS LIMITED at £0 based on an EBITDA of £-6.4k and a 3.42x industry multiple (adjusted for size and gross margin).
oncotherics limited Estimated Valuation
Pomanda estimates the enterprise value of ONCOTHERICS LIMITED at £0 based on Net Assets of £-274.5k and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Oncotherics Limited Overview
Oncotherics Limited is a live company located in leicestershire, LE12 9NP with a Companies House number of 06940617. It operates in the non-trading company sector, SIC Code 74990. Founded in June 2009, it's largest shareholder is biostatus ltd with a 39.8% stake. Oncotherics Limited is a established, micro sized company, Pomanda has estimated its turnover at £490.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Oncotherics Limited Health Check
Pomanda's financial health check has awarded Oncotherics Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs


2 Strong

1 Regular

7 Weak

Size
annual sales of £490.2k, make it smaller than the average company (£3.4m)
- Oncotherics Limited
£3.4m - Industry AVG

Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (7.2%)
- Oncotherics Limited
7.2% - Industry AVG

Production
with a gross margin of 20.2%, this company has a higher cost of product (35.6%)
- Oncotherics Limited
35.6% - Industry AVG

Profitability
an operating margin of -1.3% make it less profitable than the average company (5.3%)
- Oncotherics Limited
5.3% - Industry AVG

Employees
with 8 employees, this is below the industry average (41)
8 - Oncotherics Limited
41 - Industry AVG

Pay Structure
on an average salary of £41.8k, the company has an equivalent pay structure (£41.8k)
- Oncotherics Limited
£41.8k - Industry AVG

Efficiency
resulting in sales per employee of £61.3k, this is less efficient (£152.5k)
- Oncotherics Limited
£152.5k - Industry AVG

Debtor Days
it gets paid by customers after 0 days, this is earlier than average (37 days)
- Oncotherics Limited
37 days - Industry AVG

Creditor Days
its suppliers are paid after 277 days, this is slower than average (41 days)
- Oncotherics Limited
41 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Oncotherics Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Oncotherics Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 1261.6%, this is a higher level of debt than the average (41%)
1261.6% - Oncotherics Limited
41% - Industry AVG
ONCOTHERICS LIMITED financials

Oncotherics Limited's latest turnover from June 2024 is estimated at £490.2 thousand and the company has net assets of -£274.5 thousand. According to their latest financial statements, Oncotherics Limited has 8 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 8 | 8 | 8 | 8 | 8 | 8 | |||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 22,949 | 22,949 | 22,949 | 19,663 | 1,024 | ||||||||||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 22,949 | 22,949 | 22,949 | 19,663 | 1,024 | ||||||||||
Stock & work in progress | |||||||||||||||
Trade Debtors | 682 | 384 | 1,290 | 25,996 | 6,565 | 22,043 | 8,025 | 5,727 | 1,098 | 4,704 | 510 | 181 | |||
Group Debtors | |||||||||||||||
Misc Debtors | |||||||||||||||
Cash | 1,353 | 358 | 291 | 1,687 | |||||||||||
misc current assets | |||||||||||||||
total current assets | 682 | 384 | 1,290 | 25,996 | 6,565 | 22,043 | 8,025 | 5,727 | 2,451 | 5,062 | 801 | 1,868 | |||
total assets | 23,631 | 23,333 | 24,239 | 45,659 | 7,589 | 22,043 | 8,025 | 5,727 | 2,451 | 5,062 | 801 | 1,868 | |||
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 297,652 | 290,984 | 288,547 | 301,936 | 263,852 | 238,833 | 133,164 | 84,979 | 40,133 | 29,704 | 9,807 | 1,999 | |||
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | |||||||||||||||
total current liabilities | 297,652 | 290,984 | 288,547 | 301,936 | 263,852 | 238,833 | 133,164 | 84,979 | 40,133 | 29,704 | 9,807 | 1,999 | |||
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | 465 | 450 | 450 | 450 | 450 | 450 | |||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 465 | 450 | 450 | 450 | 450 | 450 | |||||||||
total liabilities | 298,117 | 291,434 | 288,997 | 302,386 | 264,302 | 239,283 | 133,164 | 84,979 | 40,133 | 29,704 | 9,807 | 1,999 | |||
net assets | -274,486 | -268,101 | -264,758 | -256,727 | -256,713 | -217,240 | -125,139 | -79,252 | -37,682 | -24,642 | -9,006 | -131 | |||
total shareholders funds | -274,486 | -268,101 | -264,758 | -256,727 | -256,713 | -217,240 | -125,139 | -79,252 | -37,682 | -24,642 | -9,006 | -131 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | |||||||||||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | 298 | -906 | -24,706 | 19,431 | -15,478 | 14,018 | 2,298 | 4,629 | -3,606 | 4,194 | 329 | 181 | |||
Creditors | 6,668 | 2,437 | -13,389 | 38,084 | 25,019 | 105,669 | 48,185 | 44,846 | 10,429 | 19,897 | 7,808 | 1,999 | |||
Accruals and Deferred Income | 15 | 450 | |||||||||||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -1,353 | 995 | 67 | -1,396 | 1,687 | ||||||||||
overdraft | |||||||||||||||
change in cash | -1,353 | 995 | 67 | -1,396 | 1,687 |
oncotherics limited Credit Report and Business Information
Oncotherics Limited Competitor Analysis

Perform a competitor analysis for oncotherics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in LE12 area or any other competitors across 12 key performance metrics.
oncotherics limited Ownership
ONCOTHERICS LIMITED group structure
Oncotherics Limited has no subsidiary companies.
oncotherics limited directors
Oncotherics Limited currently has 7 directors. The longest serving directors include Mr Stefan Ogrodzinski (Jun 2009) and Mrs Stephanie McKeown (Jan 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Stefan Ogrodzinski | 61 years | Jun 2009 | - | Director | |
Mrs Stephanie McKeown | Northern Ireland | 75 years | Jan 2012 | - | Director |
Mr Robert Humphries | United Kingdom | 68 years | Jun 2015 | - | Director |
Dr Roy Eady | 80 years | Jun 2015 | - | Director | |
Professor Paul Smith | 72 years | Jun 2015 | - | Director | |
Dr Thomas Morris | England | 62 years | Jan 2016 | - | Director |
Mr Roland Kozlowski | United Kingdom | 61 years | Mar 2018 | - | Director |
P&L
June 2024turnover
490.2k
+5%
operating profit
-6.4k
0%
gross margin
20.3%
+9.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
-274.5k
+0.02%
total assets
23.6k
+0.01%
cash
0
0%
net assets
Total assets minus all liabilities
oncotherics limited company details
company number
06940617
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
June 2009
age
16
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
June 2024
previous names
N/A
accountant
MARLOW PROACTIVE
auditor
-
address
56a charnwood road, shepshed, leicestershire, LE12 9NP
Bank
-
Legal Advisor
-
oncotherics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to oncotherics limited.
oncotherics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ONCOTHERICS LIMITED. This can take several minutes, an email will notify you when this has completed.
oncotherics limited Companies House Filings - See Documents
date | description | view/download |
---|